Luft F C, Rankin L I, Sloan R S, Yum M N
Antimicrob Agents Chemother. 1978 Sep;14(3):284-7. doi: 10.1128/AAC.14.3.284.
To examine the nephrotoxicity of prolonged gentamicin administration compared to the effect obtained when a less toxic aminoglycoside is substituted during the course of treatment, we gave gentamicin (67.5 mg/kg per day) to rats for 21 days, gentamicin for 14 days followed by either netilmicin or tobramycin for 7 days, or gentamicin for 14 days followed by saline diluent. After initial tubular, necrosis, the animals recovered from renal injury whether the drug was continued or discontinued or another drug was substituted. These data are consistent with the observation that regenerating renal epithelium is resistant to continued or additional nephrotoxic insults. These findings suggest that improvement in renal function during aminoglycoside therapy cannot necessarily be attributed to the substitution of another aminoglycoside or other therapeutic interventions.
为了研究与在治疗过程中换用毒性较小的氨基糖苷类药物时相比,长期给予庆大霉素的肾毒性,我们给大鼠每日注射庆大霉素(67.5毫克/千克),持续21天;或先注射14天庆大霉素,随后7天换用奈替米星或妥布霉素;或先注射14天庆大霉素,随后注射生理盐水稀释剂。在最初出现肾小管坏死之后,无论药物是继续使用、停用还是换用其他药物,动物的肾损伤均得以恢复。这些数据与再生的肾上皮细胞对持续或额外的肾毒性损伤具有抗性这一观察结果相符。这些发现表明,氨基糖苷类药物治疗期间肾功能的改善不一定归因于换用另一种氨基糖苷类药物或其他治疗干预措施。